Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toni M Brand

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Lung Cancer (Amsterdam, Netherlands)|May 1, 2013
Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancerAnne M Traynor, Tracey L Weigel, Kurt R Oettel, et al.
Molecular Cancer Therapeutics|December 12, 2013
Combined MET inhibition and topoisomerase I inhibition block cell growth of small cell lung cancerCleo E Rolle, Rajani Kanteti, Mosmi Surati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2021
Correction: Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV<sup>+</sup> PatientsToni M Brand, Stefan Hartmann, Neil E Bhola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2016
Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV<sup>+</sup> PatientsToni M Brand, Stefan Hartmann, Neil E Bhola, et al.
Molecular Cancer Therapeutics|July 17, 2016
Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to CetuximabMari Iida, Harsh Bahrar, Toni M Brand, et al.
Cancer Research|September 2, 2022
Editor's Note: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck CancerToni M Brand, Stefan Hartmann, Neil E Bhola, et al.
Cancer Research|September 2, 2022
Correction: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck CancerToni M Brand, Stefan Hartmann, Neil E Bhola, et al.
Cancer Research|February 15, 2018
Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck CancerToni M Brand, Stefan Hartmann, Neil E Bhola, et al.
Cancer Discovery|September 14, 2018
Multiple Routes to Oncogenesis Are Promoted by the Human Papillomavirus-Host Protein NetworkManon Eckhardt, Wei Zhang, Andrew M Gross, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 14, 2015
AXL Is a Logical Molecular Target in Head and Neck Squamous Cell CarcinomaToni M Brand, Mari Iida, Andrew P Stein, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Lung Cancer (Amsterdam, Netherlands)|May 1, 2013
Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancerAnne M Traynor, Tracey L Weigel, Kurt R Oettel, et al.
Molecular Cancer Therapeutics|December 12, 2013
Combined MET inhibition and topoisomerase I inhibition block cell growth of small cell lung cancerCleo E Rolle, Rajani Kanteti, Mosmi Surati, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 15, 2021
Correction: Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV<sup>+</sup> PatientsToni M Brand, Stefan Hartmann, Neil E Bhola, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 18, 2016
Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV<sup>+</sup> PatientsToni M Brand, Stefan Hartmann, Neil E Bhola, et al.
Molecular Cancer Therapeutics|July 17, 2016
Targeting the HER Family with Pan-HER Effectively Overcomes Resistance to CetuximabMari Iida, Harsh Bahrar, Toni M Brand, et al.
Cancer Research|September 2, 2022
Editor's Note: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck CancerToni M Brand, Stefan Hartmann, Neil E Bhola, et al.
Cancer Research|September 2, 2022
Correction: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck CancerToni M Brand, Stefan Hartmann, Neil E Bhola, et al.
Cancer Research|February 15, 2018
Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck CancerToni M Brand, Stefan Hartmann, Neil E Bhola, et al.
Cancer Discovery|September 14, 2018
Multiple Routes to Oncogenesis Are Promoted by the Human Papillomavirus-Host Protein NetworkManon Eckhardt, Wei Zhang, Andrew M Gross, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 14, 2015
AXL Is a Logical Molecular Target in Head and Neck Squamous Cell CarcinomaToni M Brand, Mari Iida, Andrew P Stein, et al.
Pageof 4